PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)



Similar documents
PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Jeffrey Sparks Brigham and Women's Hospital Harvard Medical School USA 25-Nov-2015

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Elizabeth Comino Centre fo Primary Health Care and Equity 12-Aug-2015

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Quality Standards Rheumatoid Arthritis

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Dingcheng Li Mayo Clinic, USA 20-Dec-2015

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Tatyana A Shamliyan. I do not have COI. 30-May-2012

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Anna Sinaiko Harvard School of Public Health United States of America 20-Dec-2013

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Avinesh Pillai Department of Statistics University of Auckland New Zealand 16-Jul-2015

PEER REVIEW HISTORY ARTICLE DETAILS

Critical Appraisal of a Research Paper

Josefine Persson Institution of Neuroscience and physiology, the Sahlgrenska academy at Gothenburg university, Sweden. 26-May-2015

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Saket Girotra University of Iowa, Iowa City, IA United States 04-Aug-2015

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Treat to Target Approach in Rheumatoid Arthritis: UK perspective. Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK

Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Carrieri, Vicenzo University of Salerno 19-Jun-2013

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Richard Franklin James Cook University, Australia 15-Jun-2015.

Middle School Initiative PART I COVER SHEET. COURSE: Leadership Officer Staff Duty Analysis, Achievement 12

A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis

The Euclidean Algorithm

Case-control studies. Alfredo Morabia

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Treating Rheumatoid Arthritis to Target : the patient version of the international recommendations

Dr Sarah Levy Consultant Rheumatology Croydon University Hospital

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Fogelholm, Mikael University of Helsinki 19-Jul-2015

Rheumatoid Arthritis Support and Education Programs

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Alzheimer s and memory loss

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Hongcai Shang Beijing university of Chinese medicine, China 11-Nov-2015

Using EHRs to extract information, query clinicians, and insert reports

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Arthritis Research UK Epidemiology Unit

National Rheumatoid Arthritis Society. THE ECONOMIC BURDEN OF RHEUMATOID ARTHRITIS March 2010

Title: Genetic Discrimination and Life Insurance: A Systematic Review of the Evidence

We have addressed all reviewers comments as described below. We have no potential conflict of interest to report.

Medical Insurance Long Term (chronic) Conditions Explained

WORKERS COMPENSATION APPEAL TRIBUNAL. EMPLOYER CASE ID #[personal information] WORKERS COMPENSATION BOARD OF PRINCE EDWARD ISLAND WORKER DECISION #114

Knowledge-based systems and the need for learning

TRANSFoRm: TRANSFoRming health care research and its implementation

Derek Corrigan Work Package Lead: WP4 Decision Rules and Evidence Royal College of Surgeons in Ireland

General & Medical. Guide to Underwriting Terms

Evaluating the ENAT : reconciling findings from a mixed methods study

Organizing Your Approach to a Data Analysis

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

UNDERSTANDING THE TRILLIUM DRUG PROGRAM

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Dr Andreas Xyrichis King's College London, UK 14-Jun-2015

Rheumatoid Arthritis foot health education survey for practitioners

A GUIDE TO LABORATORY REPORT WRITING ILLINOIS INSTITUTE OF TECHNOLOGY THE COLLEGE WRITING PROGRAM

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

Electronic Health Records Research in a Health Sector with Multiple Provider Types

Big Data in Biobanking towards targeted medicine

Produced by the Deloitte Center for Health Solutions. Issue Brief: Physician perspectives about health information technology

Q&A. What Are Co-occurring Disorders?

EHR4CR ENABLING PROACTIVE RESEARCH

1. Title 2. Background

Guidelines for Documentation of Attention Deficit/Hyperactivity Disorder In Adolescents and Adults

Patient derived follow-up data (PREMs, PROMs and Work) (to be collected at 3 months)

The FOS Approach Section 47 of the Insurance Contracts Act

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

11/8/2011. Administrative Definitions of Rheumatoid Arthritis: Rising Prevalence Regardless of Definition Used. No Disclosures. Background.

Identifying and treating long-term kidney problems (chronic kidney disease)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

DOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS

Acute Hepatitis C Surveillance using Electronic Health Record Data

Guidelines for AJO-DO submissions: Randomized Clinical Trials June 2015

Identifying and Prioritizing Research Gaps. Tim Carey, M.D., M.P.H. Amica Yon, Pharm.D. Chris Beadles, M.D. Roberta Wines, M.P.H.

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Lepelletier Nantes University Hospital, Nantes, France 20-Jul-2015

Acute pelvic inflammatory disease: tests and treatment

How To Understand And Understand The Relationship Between Patient And Physician Mistrust In China

Chapter 6 Experiment Process

Services for people with rheumatoid arthritis

Rheumatoid Arthritis

Pathology Australia Budget Submission

Updating Rheumatology Skills in Primary Care: The Maine Arthritis Partnership (MAP) Program

Author's response to reviews

CASE STUDY. Portsmouth and South East Hampshire diabetes service

Improving EHR Semantic Interoperability Future Vision and Challenges

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Fluctuating conditions, fluctuating support: Improving organisational resilience to fluctuating conditions in the workforce

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Transcription:

PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below. ARTICLE DETAILS TITLE (PROVISIONAL) AUTHORS What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text Ford, Elizabeth; Carroll, John; Smith, H; Davies, Kevin; Koeling, Rob; Petersen, Irene; Rait, Greta; Cassell, Jacqueline VERSION 1 - REVIEW Jessica Widdifield McGill University 23-Nov-2015 The Study: The results of this study suggest that free text information relevant to RA diagnosis can often be found under correspondence codes, general consultation codes and general symptom codes. While this current study is potentially useful data, I have several general comments. Results & Conclusions: The findings suggest that up to 22% of patients may experience a delay in the coding of their RA diagnosis. However, the critical issue is that the authors fail to quantify the number of RA patients who experience no diagnostic coding for RA. The authors make an excellent case regarding issues of missing or delayed diagnostic codes in the introduction, but the work is only focused on delayed coding (which has less impact on researchers and clinical care than if RA codes are missing altogether). Given that the study sample is drawn from all cases with at least one diagnostic code of RA, the results reported may be biased if the text information captured in these patients EHRs is different from those patients who are completely missing diagnostic codes for RA. Moreover, recent studies from the UK CPRD report that the prevalence of RA (by diagnostic codes) is much lower (~0.5%) in comparison to recent international studies (~1.0%). This raises concerns regarding the poor sensitivity of RA diagnostic codes in the CPRD & how free text information could possibly improve case detection in the CRPD. While the delay in diagnostic coding may be important, it would be much more useful if the authors could also contribute information on the impact of free text diagnoses for those with missing RA codes. General comments: Discussion line 45 Very little previous work has sought to use text to establish delayed recording of diagnosis in electronic health records research. This is a rapidly growing field and numerous studies are incorporating free text into EHR research. Conclusion Natural language processing techniques have the

potential to extract information from text at scale. The authors mention this methodology in the conclusion but fail to comment on this methodology in the previous sections. Rather, the discussion mentions automated text analysis systems, which is not always Natural language processing techniques. Figure 1 label axes Tables when reporting % of all strings, perhaps incorporate % of unique patients. Limitations RA is a heterogeneous disease, and there may be delays in establishing a diagnosis; DMARDs initiated for inflammatory arthritis, which evolved into RA, may not necessarily reflect a delay in diagnosis code, but rather a delay in the clinician establishing a definitive diagnosis. Title Rheumatoid arthritis in UK general practice what can free text tell us about diagnostic recording? Perhaps the authors could incorporate a more accurate description of the study with respects to the delay of diagnostic coding. Mark Nielen NIVEL, Utrecht, the Netherlands 14-Dec-2015 Major comments: - This is an interesting study which describes the additional value of using free text fields when determining the date of diagnosis of RA. The research question is very clear, however, the main issue of the manuscript is that there are a large number of very detailed tables which are not needed to answer the research questions. This not only resulted in a very complicated manuscript, but it is also difficult to find the main message: does using free text form EHRs increase the number of incident RA cases? And to what extent does this influence the date of diagnosis? The manuscript would improve when only results are shown that can be used to answer the research question. - I do not understand why in table 3 the author report on text level instead of patient level. The most important outcome of the study is whether free text fields influence the date of diagnosis in newly diagnosed RA patients. - Introduction: there is so much information given in the introduction that the purpose of the study is not completely clear: why did the authors use rheumatoid arthritis as an example? Why is it so important to study this subject? Is it only a problem for selecting study populations for research or does it also influence care? - I have some privacy concerns. Is it allowed to extract free text fields from EHRs in the UK? What happened when the GP entered for instance a name or phone number of a patient in their HER? - The authors used data from 2005-2008. In the Netherlands data quality improved a lot the last five years. This issue of data quality should be added to the discussion section. When recording diagnosis by the GP improves, it is very likely that in 2015 using free text field does not add as much as in the period 2005-2008. Minor comments: - I do not know the concept of Read codes. Could you please add more information about this method in the method section? Also, please remove the example about these code from the introduction to the method section.

- Why did the authors randomly select 294 cases? Was this based on a power analysis? - The study is mainly focused on the UK. A comparison with studies in primary care of other countries is missing. VERSION 1 AUTHOR RESPONSE Reviewer 1 3) Title Rheumatoid arthritis in UK general practice what can free text tell us about diagnostic recording? Perhaps the authors could incorporate a more accurate description of the study with respects to the delay of diagnostic coding. - We have changed the title on page 1 to: What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text 4) Results: The findings suggest that up to 22% of patients may experience a delay in the coding of their RA diagnosis. However, the critical issue is that the authors fail to quantify the number of RA patients who experience no diagnostic coding for RA the work is only focused on delayed coding (which has less impact on researchers and clinical care than if RA codes are missing altogether). Results reported may be biased if the text information captured in these patients EHRs is different from those patients who are completely missing diagnostic codes for RA. - Many thanks for your comments. We agree that the idea that codes may be missing for RA is mere speculation based on this data, so we have re-written the introduction to reflect that the study only evaluates delayed coding (pages 4-7). We have speculated on missing codes in the discussion and suggested further work should be done to quantify this (page 16). 5) Moreover, recent studies from the UK CPRD report that the prevalence of RA (by diagnostic codes) is much lower (~0.5%) in comparison to recent international studies (~1.0%). This raises concerns regarding the poor sensitivity of RA diagnostic codes in the CPRD & how free text information could possibly improve case detection in the CRPD. While the delay in diagnostic coding may be important, it would be much more useful if the authors could also contribute information on the impact of free text diagnoses for those with missing RA codes. - We would love to reference this prevalence study in the discussion but after an extensive search, we cannot find the paper you refer to. Discussion: 6) This is a rapidly growing field and numerous studies are incorporating free text into EHR research. - Yes we agree and have included a new paragraph on this topic (page 15-16). However, the bulk of these free text studies are being performed on US-based hospital records data, (see my 2016 JAMIA review of the literature for more detail; https://jamia.oxfordjournals.org/content/early/2016/02/04/jamia.ocv180). However, very few research groups are using CPRD free text due to cost and governance issues. 7) Natural language processing techniques have the potential to extract information from text at scale. The authors mention this methodology in the conclusion but fail to comment on this methodology in the previous sections. Rather, the discussion mentions automated text analysis systems, which is not always Natural language processing techniques. - We have homogenised terms for consistency (page 16-18). 8) Limitations RA is a heterogeneous disease, and there may be delays in establishing a diagnosis; DMARDs initiated for inflammatory arthritis, which evolved into RA, may not necessarily reflect a delay in diagnosis code, but rather a delay in the clinician establishing a definitive diagnosis. - We investigated the idea that patients receiving DMARDS before RA code may have had an inflammatory arthritis diagnosis. We found they had more text entries regarding inflammatory arthritis but found no more inflammatory arthritis codes than the comparison group (added to results, page 18). We included this possibility in the discussion (page 17). 9) Figure 1 label axes

- We have added labels to both axes of the table. 10) Tables when reporting % of all strings, perhaps incorporate % of unique patients. - As per reviewer 2 s comments we have changed table 3 and integrated the information from tables 3 and 4 to form a single table, thus streamlining presentation of the results. Reviewer 2 11) The main issue of the manuscript is that there are a large number of very detailed tables which are not needed to answer the research questions - Thank you for your comment. We have integrated tables 3 and 4 into a single table and removed the supplementary tables from the paper (page 11-12). 12) It is also difficult to find the main message: does using free text form EHRs increase the number of incident RA cases? And to what extent does this influence the date of diagnosis? - Thank you for your comments, we have changed the rationale for the paper, and the discussion, the rationale is now both clearer and more succinct. 13) Introduction: the purpose of the study is not completely clear: why did the authors use rheumatoid arthritis as an example? Why is it so important to study this subject? Is it only a problem for selecting study populations for research or does it also influence care? - As above, we have taken on board your comments and have substantially re-written the introduction and discussion, we feel this is a better reflection of the analysis undertaken and makes the main message of the paper clear. 14) I do not understand why in table 3 the author report on text level instead of patient level. The most important outcome of the study is whether free text fields influence the date of diagnosis in newly diagnosed RA patients. - We have changed table 3 to report on the patient level statistics and have combined this with table 4 (page 11-12). 15) Is it allowed to extract free text fields from EHRs in the UK? What happened when the GP entered for instance a name or phone number of a patient in their EHR? - The governance issues around extracting free text from GP records are complicated. Currently (since 2013) CPRD are not allowed to extract any information from GP practices which contains patient identifiers, this means the free text can no longer be extracted. However, historically, the free text was extracted to CPRD and only released to researchers after a 3 stage anonymization process, hence the substantial cost of accessing the data. This is made clear in the paragraph Free text data in the methods on page 9. 16) The authors used data from 2005-2008. In the Netherlands data quality improved a lot the last five years. This issue of data quality should be added to the discussion section. When recording diagnosis by the GP improves, it is very likely that in 2015 using free text field does not add as much as in the period 2005-2008. - We agree this is likely to be true so have added a sentence suggesting this in the discussion (page 20). 17) I do not know the concept of Read codes. Could you please add more information about this method in the method section? Also, please remove the example about these code from the introduction to the method section. - A section has been included in the methods to describe Read codes, however we have decided to leave the examples about the codes and free text in the introduction as we feel it illustrates our introductory rationale that the code may only be a partial summary of the clinical information. 18) Why did the authors randomly select 294 cases? Was this based on a power analysis? - The rationale for the sample size is given on page 8 in the paragraph Identification of cases. 19) The study is mainly focused on the UK. A comparison with studies in primary care of other countries is missing. - We have added this point to the discussion as a limitation (page 17-18) as these results cannot inform us about delays in coding in other primary care systems.

VERSION 2 REVIEW Mark Nielen NIVEL, Utrecht, the Netherlands 07-Mar-2016 The reviewer completed the checklist but made no further comments.